1. Home
  2. NERV vs DTCK Comparison

NERV vs DTCK Comparison

Compare NERV & DTCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NERV
  • DTCK
  • Stock Information
  • Founded
  • NERV 2007
  • DTCK 1999
  • Country
  • NERV United States
  • DTCK Singapore
  • Employees
  • NERV N/A
  • DTCK N/A
  • Industry
  • NERV Biotechnology: Pharmaceutical Preparations
  • DTCK Farming/Seeds/Milling
  • Sector
  • NERV Health Care
  • DTCK Industrials
  • Exchange
  • NERV Nasdaq
  • DTCK Nasdaq
  • Market Cap
  • NERV 12.4M
  • DTCK 14.7M
  • IPO Year
  • NERV 2014
  • DTCK 2023
  • Fundamental
  • Price
  • NERV $1.52
  • DTCK $0.64
  • Analyst Decision
  • NERV Hold
  • DTCK
  • Analyst Count
  • NERV 1
  • DTCK 0
  • Target Price
  • NERV $5.00
  • DTCK N/A
  • AVG Volume (30 Days)
  • NERV 5.9K
  • DTCK 57.8K
  • Earning Date
  • NERV 05-13-2025
  • DTCK 04-30-2025
  • Dividend Yield
  • NERV N/A
  • DTCK N/A
  • EPS Growth
  • NERV N/A
  • DTCK N/A
  • EPS
  • NERV 0.82
  • DTCK N/A
  • Revenue
  • NERV N/A
  • DTCK $132,369,000.00
  • Revenue This Year
  • NERV N/A
  • DTCK N/A
  • Revenue Next Year
  • NERV N/A
  • DTCK N/A
  • P/E Ratio
  • NERV $1.95
  • DTCK N/A
  • Revenue Growth
  • NERV N/A
  • DTCK N/A
  • 52 Week Low
  • NERV $1.15
  • DTCK $0.40
  • 52 Week High
  • NERV $3.69
  • DTCK $1.73
  • Technical
  • Relative Strength Index (RSI)
  • NERV 40.93
  • DTCK 51.23
  • Support Level
  • NERV $1.58
  • DTCK $0.48
  • Resistance Level
  • NERV $1.74
  • DTCK $0.66
  • Average True Range (ATR)
  • NERV 0.06
  • DTCK 0.09
  • MACD
  • NERV -0.01
  • DTCK 0.01
  • Stochastic Oscillator
  • NERV 0.00
  • DTCK 53.12

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

About DTCK Davis Commodities Limited

Davis Commodities Ltd is an agricultural commodity trading company based in Singapore which specializes in trading of three main categories of agricultural commodities namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.

Share on Social Networks: